Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
As of February 2026 , BPC-157 returned to Category 1 compounding status meaning licensed 503A and 503B compounding pharmacies can legally prepare it under physician prescription
With a focus on personalized care, professional guidance, and a supportive community, you can confidently pursue your health goals and embrace a healthier, more balanced lifestyle
This appetite-neutral characteristic distinguishes AOD-9604 from medications like GLP-1 agonists (Semaglutide, Tirzepatide) that work primarily through appetite suppression
This is an area where the mechanism is well-characterized, the animal data is robust, and the safety profile appears favorable, but rigorous human trial data remains limited
GLOW Dosing Protocol The standard protocol for GLOW is dosed at 2.8 mg per injection: 2 mg GHK-Cu with 400 mcg each of BPC-157 and TB-4
To get a prescription, talk to a healthcare provider
US$ 20.92
US$ 24.96
US$ 28.67
US$ 29.86
US$ 22.47
US$ 23.82
US$ 29.26